ClinicalTrials.govpublic full text
Temozolomide in Treating Young Patients With Refractory or Recurrent Leukemia
leukemia, recurrent childhood acute lymphoblastic leukemia, recurrent childhood acute myeloid leukemia, relapsing chronic myelogenous leukemia, childhood acute promyelocytic leukemia (m3), blastic phase chronic myelogenous leukemia, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 848321
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.